Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease

Leukemia

Volumn 29, Issue 6, 2015, Pages 1360-1365

  Mauro, F R ^a   Chauvie, S ^b   Paoloni, F ^c   Biggi, A ^b   Cimino, G ^a   Rago, A ^a   Gentile, M ^d   Morabito, F ^d   Coscia, M ^e   Bello M ^e   Sacchetti, G M ^f   Rossi, D ^f   Laurenti, L ^g   Autore, F ^g   Campanelli, M ^a   Trastulli, F ^a   Nicolai, E ^h   Riminucci, M ⁱ   Gaidano, G ^f   Guarini, A ^a   Gallamini, A ^j   Foa R ^a,b   more..

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b S CROCE E CARLE HOSPITAL   (Italy)

^c Italian Group for Adult Hematologic Diseases GIMEMA Data Center   (Italy)

^d Unit of Geriatrics   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^g CATHOLIC UNIVERSITY   (Italy)

^h IRCCS SDN   (Italy)

ⁱ SAPIENZA UNIVERSITY OF ROME   (Italy)

^j CENTRE ANTOINE LACASSAGNE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD38 ANTIGEN; PROTEIN KINASE ZAP 70; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOME 17P; CHROMOSOME DELETION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MUTATION; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPH NODE BIOPSY; LYMPHOCYTOMA; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PET-CT SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RETROSPECTIVE STUDY; RICHTER SYNDROME; SECOND CANCER; SENSITIVITY AND SPECIFICITY; TRISOMY 12; VERY ELDERLY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; NEOPLASMS, SECOND PRIMARY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HODGKIN DISEASE; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84930574902     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2015.21     Document Type: Article

References (27)

1. Chiorazzi N, Rai KR, Ferrarini M. Chronic lymphocytic leukemia. N Engl J Med 2005; 352: 804-8015.
2. Tsimberidou AM, Wen S, McLaughlin P, O'Brien S, Wierda WG, Lerner S et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. J Clin Oncol 2009; 27: 904-910.
3. Rossi D, Spina V, Deambrogi C, Rasi S, Laurenti L, Stamatopoulos K et al. The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation. Blood 2011; 117: 3391-3401.
4. Parikh SA, Rabe KG, Call TG, Zent CS, Habermann TM, Ding W et al. Diffuse large B-cell lymphoma (Richter syndrome) in patients with chronic lymphocytic leukaemia (CLL): A cohort study of newly diagnosed patients. Br J Haematol 2013; 162: 774-782.
5. Parikh SA, Kay NE, Shanafelt TD. How we treat Richter syndrome. Blood 2014; 123: 1647-1657.
6. Giné E, Martinez A, Villamor N, López-Guillermo A, Camos M, Martinez D et al. Expanded and highly active proliferation centers identify a histological subtype of chronic lymphocytic leukemia (accelerated' chronic lymphocytic leukemia) with aggressive clinical behavior. Haematologica 2010; 95: 1526-1533.
7. Herishanu Y, Pérez-Galán P, Liu D, Biancotto A, Pittaluga S, Vire B et al. The lymph node microenvironment promotes B-cell receptor signaling, NF-{kappa}B activation, and tumor proliferation in chronic lymphocytic leukemia. Blood 2011; 117: 563-574.
8. Ciccone M, Agostinelli C, Rigolin GM, Piccaluga PP, Cavazzini F, Righi S et al. Proliferation centers in chronic lymphocytic leukemia: correlation with cytogenetic and clinic-biological features in consecutive patients analyzed on tissue microarrays. Leukemia 2012; 26: 499-508.
9. Kostakoglu L, Cheson BD. Current role of FDG PET/CT in lymphoma. Eur J Nucl Med Mol Imaging 2014; 41: 1004-1027.
10. Gallamini A, Borra A. Role of PET in Lymphoma. Curr Treat Options Oncol 2014; 15: 248-261.
11. Gallamini A, Barrington SF, Biggi A, Chauvie S, Kostakoglu L, Gregianin M et al. The predictive role of interim Positron Emission Tomography on Hodgkin lymphoma treatment outcome is confirmed using the 5-point scale interpretation criteria. Haematologica 2014; 99: 1107-1113.
12. Kajáry K, Molnár Z, Györke T, Szakáll S Jr, Molnár P, Lengyel Z. Comparison of the International Harmonization Project, London and Gallamini criteria in the interpretation of 18 F-FDG PET/CT examinations after first-line treatment in Hodgkin's lymphoma. Nucl Med Commun 2014; 35: 169-175.
13. Casasnovas RO, Meignan M, Berriolo-Riedinger A, Bardet S, Julian A, Thieblemont C et al. SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood 2011; 118: 37-43.
14. Trotman J, Fournier M, Lamy T, Seymour JF, Sonet A, Janikova A et al. Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: analysis of PET-CT in a subset of PRIMA trial participants. J Clin Oncol 2011; 29: 3194-3200.
15. Luminari S, Biasoli I, Versari A, Rattotti S, Bottelli C, Rusconi C et al. The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: A subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL). Ann Oncol 2014; 25: 442-447.
16. Schöder H, Noy A, Gönen M, Weng L, Green D, Erdi YE et al. Intensity of 18fluorodeoxyglucose uptake in positron emission tomography distinguishes between indolent and aggressive non-Hodgkin's lymphoma. J Clin Oncol 2005; 23: 4643-4651.
17. Bruzzi JF, Macapinlac H, Tsimberidou AM, Truong MT, Keating MJ, Marom EM et al. Detection of Richter's transformation of chronic lymphocytic leukemia by PET/CT. J Nucl Med 2006; 47: 1267-1273.
18. Conte MJ, Bowen DA, Wiseman GA, Rabe KG, Slager SL, Schwager SM et al. Use of positron emission tomography-computerized tomography (PET-CT) in the management of patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Leuk Lymphoma 2014; 55: 2079-2084.
19. Papajík T, Mysliveek M, Urbanová R, Buriánková E, Kapitáová Z, Procházka V et al. 2-[18 F]fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography examination in patients with chronic lymphocytic leukemia may reveal Richter transformation. Leuk Lymphoma 2014; 55: 314-319.
20. Falchi L, Keating MJ, Marom EM, Truong MT, Schlette EJ, Sargent RL et al. Correlation between FDG/PET findings, histological features, clinical characteristics and survival in 332 patients with chronic lymphocytic leukemia. Blood 2014; 123: 2783-2790.
21. Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, Döhner H et al. International Workshop on Chronic Lymphocytic Leukemia. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: A report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. [published erratum appears in Blood 2008; 112: 5259] Blood 2008; 111: 5446-5456.
22. Binet JL, Auquier A, Dighiero G, Chastang C, Piguet H, Goasguen J et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer 1981; 48: 198-204.
23. Chauvie S, Biggi A, Stancu A, Cerello P, Cavallo A, Fallanca F et al. A tool for medical image management in multicenter clinical trials. Clinical Trials 2014; 11: 355-361.
24. Swerdlow S, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edn, vol. 2. WHO Classification of Tumours, 2008.
25. Gaidano G, Foà R, Dalla-Favera R. Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest 2012; 122: 3432-3428.
26. Messina M, Del Giudice I, Khiabanian H, Rossi D, Chiaretti S, Rasi S et al. Genetic lesions associated with chronic lymphocytic leukemia chemo-refractoriness. Blood 2014; 123: 2378-2388.
27. Döhner H, Stilgenbauer S, James MR, Benner A, Weilguni T, Bentz M et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. Blood 1997; 89: 2516-2522.